NasdaqGM - Nasdaq Real Time Price USD
Carisma Therapeutics, Inc. (CARM)
0.1905
-0.0248
(-11.52%)
At close: May 9 at 4:00:00 PM EDT
0.2059
+0.02
+(8.08%)
After hours: May 9 at 7:59:18 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 2 |
| Avg. Estimate | -0.1 | -0.06 | -0.5 | -0.56 |
| Low Estimate | -0.12 | -0.07 | -0.88 | -0.6 |
| High Estimate | -0.08 | -0.05 | -0.28 | -0.51 |
| Year Ago EPS | -0.46 | -0.27 | -1.46 | -0.5 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 2 |
| Avg. Estimate | 2.47M | 2.53M | 16.91M | 9.11M |
| Low Estimate | -- | -- | 15M | -- |
| High Estimate | 3.75M | 3.84M | 20M | 18.23M |
| Year Ago Sales | 3.4M | 9.2M | 19.63M | 16.91M |
| Sales Growth (year/est) | -27.36% | -72.51% | -13.84% | -46.12% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.39 | -0.36 | -0.36 | -0.16 |
| EPS Actual | -0.46 | -0.27 | -0.31 | -0.42 |
| Difference | -0.07 | 0.09 | 0.05 | -0.26 |
| Surprise % | -18.96% | 25.00% | 13.89% | -158.46% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.1 | -0.06 | -0.5 | -0.56 |
| 7 Days Ago | -0.18 | -0.17 | -0.62 | -0.41 |
| 30 Days Ago | -0.18 | -0.17 | -0.62 | -0.41 |
| 60 Days Ago | -0.18 | -0.17 | -0.62 | -0.41 |
| 90 Days Ago | -0.18 | -0.17 | -0.54 | -0.41 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CARM | 78.26% | 77.78% | 65.75% | -11.00% |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 4/1/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 1/17/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 1/13/2025 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 12/16/2024 |
| Maintains | D. Boral Capital: Buy to Buy | 12/12/2024 |
| Downgrade | Baird: Outperform to Neutral | 12/12/2024 |
Related Tickers
RLMD Relmada Therapeutics, Inc.
0.4195
+15.47%
ONCO Onconetix, Inc.
0.0720
-1.10%
VOR Vor Biopharma Inc.
0.1513
-5.44%
TNFA TNF Pharmaceuticals, Inc.
0.1900
-3.36%
CYCC Cyclacel Pharmaceuticals, Inc.
0.2534
-15.53%
PCSA Processa Pharmaceuticals, Inc.
0.2390
-12.77%
BOLT Bolt Biotherapeutics, Inc.
0.3580
-3.24%
ADVM Adverum Biotechnologies, Inc.
2.8100
-9.94%
ZVSA ZyVersa Therapeutics, Inc.
0.5272
-7.70%
HEPA Hepion Pharmaceuticals, Inc.
0.3916
-0.61%